Home › Funds › Vivo Capital, LLC › INM
Vivo Capital, LLC position in INM
InMed Pharmaceuticals Inc · Health Care
Vivo Capital, LLC reported holding 824,874 shares of INM (InMed Pharmaceuticals Inc) in its Q3 2026 13F filing — a position valued at US$1.1M, representing 0.13% of its reported portfolio and ranking #45 among its reported holdings. Vivo Capital, LLC has disclosed INM holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Vivo Capital, LLC's INM position evolved
Vivo Capital, LLC first disclosed a stake in INM in Q2 2026 at 798,377 shares (US$1.2M). Across 2 filings, Vivo Capital, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 824,874 shares valued at US$1.1M — an increase of 26,497 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 798.38K | $1.24M | New |
| Q3 2026 | 824.87K | $1.12M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About INM and 13F data
INM (InMed Pharmaceuticals Inc) is a Health Care company. 17 other funds we track also report a position in INM — the largest reported positions include Squadron Capital Management LLC (US$504K), Ursa Fund Management, LLC (US$195K), Venrock Adviser, LLC (US$51K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding INM
- Squadron Capital Management LLC 325.00K sh · $503.75K · Q2 2026
- Ursa Fund Management, LLC 125.80K sh · $194.99K · Q2 2026
- Venrock Adviser, LLC 32.69K sh · $50.66K · Q2 2026
More on Vivo Capital, LLC
FAQ
How long has Vivo Capital, LLC held INM?
Vivo Capital, LLC has disclosed INM holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Vivo Capital, LLC's current position in INM?
As of Q3 2026, Vivo Capital, LLC holds 824.87K shares of INM (InMed Pharmaceuticals Inc), valued at $1.12M, representing 0.13% of its reported portfolio and ranking #45.
Has Vivo Capital, LLC been buying or selling INM?
In the latest 13F filing (Q3 2026), Vivo Capital, LLC increased its position in INM.
Which other funds hold INM?
Other major institutional holders of INM include Squadron Capital Management LLC, Ursa Fund Management, LLC, Venrock Adviser, LLC, among 17 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.